tiprankstipranks
Advertisement
Advertisement
Biomea Fusion reports Q1 EPS (17c), consensus (19c)
PremiumThe FlyBiomea Fusion reports Q1 EPS (17c), consensus (19c)
2M ago
Biomea Fusion options imply 18.9% move in share price post-earnings
Premium
The Fly
Biomea Fusion options imply 18.9% move in share price post-earnings
2M ago
Biomea Fusion options imply 23.1% move in share price post-earnings
Premium
The Fly
Biomea Fusion options imply 23.1% move in share price post-earnings
2M ago
Biomea Fusion Advances Phase 2 Add-On Therapy Trial in Ozempic-Treated Diabetes
PremiumCompany AnnouncementsBiomea Fusion Advances Phase 2 Add-On Therapy Trial in Ozempic-Treated Diabetes
3M ago
Biomea Fusion Advances Mid‑Stage Diabetes Trial, Adding a New Angle to the BMEA Investment Story
Premium
Company Announcements
Biomea Fusion Advances Mid‑Stage Diabetes Trial, Adding a New Angle to the BMEA Investment Story
3M ago
Biomea Fusion doses first patient in COVALENT-211, COVALENT-212 trials
Premium
The Fly
Biomea Fusion doses first patient in COVALENT-211, COVALENT-212 trials
3M ago
Biomea Fusion Highlights Diabetes Pipeline at JPM Conference
PremiumCompany AnnouncementsBiomea Fusion Highlights Diabetes Pipeline at JPM Conference
6M ago
Biomea Fusion initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Biomea Fusion initiated with a Buy at Rodman & Renshaw
6M ago
Biomea Fusion enters 2026 focused on icovamenib, BMF-650 milestones
Premium
The Fly
Biomea Fusion enters 2026 focused on icovamenib, BMF-650 milestones
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100